{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:40:36Z","timestamp":1793997636288,"version":"4.8.0"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurosci"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1038\/s41583-022-00641-1","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T14:10:39Z","timestamp":1667225439000},"page":"23-39","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":435,"title":["Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders"],"prefix":"10.1038","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9862-0977","authenticated-orcid":false,"given":"Ashley N.","family":"Brandebura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Paumier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik S.","family":"Onur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7542-5930","authenticated-orcid":false,"given":"Nicola J.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"641_CR1","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.conb.2013.06.004","volume":"23","author":"NJ Allen","year":"2013","unstructured":"Allen, N. J. Role of glia in developmental synapse formation. Curr. Opin. Neurobiol. 23, 1027\u20131033 (2013).","journal-title":"Curr. Opin. Neurobiol."},{"key":"641_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2017.09.056","volume":"96","author":"NJ Allen","year":"2017","unstructured":"Allen, N. J. & Eroglu, C. Cell biology of astrocyte-synapse interactions. Neuron 96, 697\u2013708 (2017).","journal-title":"Neuron"},{"key":"641_CR3","doi-asserted-by":"publisher","first-page":"a020370","DOI":"10.1101\/cshperspect.a020370","volume":"7","author":"W-S Chung","year":"2015","unstructured":"Chung, W.-S., Allen, N. J. & Eroglu, C. Astrocytes control synapse formation, function, and elimination. Cold Spring Harb. Perspect. Biol. 7, a020370 (2015).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"641_CR4","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nn.4043","volume":"18","author":"BS Khakh","year":"2015","unstructured":"Khakh, B. S. & Sofroniew, M. V. Diversity of astrocyte functions and phenotypes in neural circuits. Nat. Neurosci. 18, 942\u2013952 (2015).","journal-title":"Nat. Neurosci."},{"key":"641_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2004.12.020","volume":"120","author":"KS Christopherson","year":"2005","unstructured":"Christopherson, K. S. et al. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120, 421\u2013433 (2005).","journal-title":"Cell"},{"key":"641_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nature11059","volume":"486","author":"NJ Allen","year":"2012","unstructured":"Allen, N. J. et al. Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature 486, 410\u2013414 (2012).","journal-title":"Nature"},{"key":"641_CR7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature12776","volume":"504","author":"W-S Chung","year":"2013","unstructured":"Chung, W.-S. et al. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature 504, 394\u2013400 (2013).","journal-title":"Nature"},{"key":"641_CR8","doi-asserted-by":"publisher","first-page":"E440","DOI":"10.1073\/pnas.1104977108","volume":"108","author":"H Kucukdereli","year":"2011","unstructured":"Kucukdereli, H. et al. Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. Proc. Natl Acad. Sci. USA 108, E440\u2013E449 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"641_CR9","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.neuron.2018.09.043","volume":"100","author":"E Blanco-Suarez","year":"2018","unstructured":"Blanco-Suarez, E., Liu, T.-F., Kopelevich, A. & Allen, N. J. Astrocyte-secreted chordin-like 1 drives synapse maturation and limits plasticity by increasing synaptic GluA2 AMPA receptors. Neuron 100, 1116\u20131132.e1113 (2018).","journal-title":"Neuron"},{"key":"641_CR10","doi-asserted-by":"publisher","first-page":"a020396","DOI":"10.1101\/cshperspect.a020396","volume":"7","author":"B Weber","year":"2015","unstructured":"Weber, B. & Barros, L. F. The astrocyte: powerhouse and recycling center. Cold Spring Harb. Perspect. Biol. 7, a020396 (2015).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"641_CR11","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190062","volume":"217","author":"CP Profaci","year":"2020","unstructured":"Profaci, C. P., Munji, R. N., Pulido, R. S. & Daneman, R. The blood-brain barrier in health and disease: Important unanswered questions. J. Exp. Med. 217, e20190062 (2020).","journal-title":"J. Exp. Med."},{"key":"641_CR12","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.neuron.2014.02.007","volume":"81","author":"A Araque","year":"2014","unstructured":"Araque, A. et al. Gliotransmitters travel in time and space. Neuron 81, 728\u2013739 (2014).","journal-title":"Neuron"},{"key":"641_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.celrep.2017.12.039","volume":"22","author":"M Boisvert","year":"2018","unstructured":"Boisvert, M., Erikson, G., Shokhirev, M. & Allen, N. The aging astrocyte transcriptome from multiple regions of the mouse brain. Cell Rep. 22, 269\u2013285 (2018).","journal-title":"Cell Rep."},{"key":"641_CR14","doi-asserted-by":"publisher","first-page":"E1896","DOI":"10.1073\/pnas.1800165115","volume":"115","author":"LE Clarke","year":"2018","unstructured":"Clarke, L. E. et al. Normal aging induces A1-like astrocyte reactivity. Proc. Natl Acad. Sci. USA 115, E1896\u2013E1905 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"641_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2013.07.008","volume":"35","author":"M Orre","year":"2014","unstructured":"Orre, M. et al. Acute isolation and transcriptome characterization of cortical astrocytes and microglia from young and aged mice. Neurobiol. Aging 35, 1\u201314 (2014).","journal-title":"Neurobiol. Aging"},{"key":"641_CR16","doi-asserted-by":"publisher","first-page":"eaaw8546","DOI":"10.1126\/scitranslmed.aaw8546","volume":"11","author":"B Diaz-castro","year":"2019","unstructured":"Diaz-castro, B., Gangwani, M. R., Yu, X., Coppola, G. & Khakh, B. S. Astrocyte molecular signatures in Huntington\u2019s disease. Sci. Transl. Med. 11, eaaw8546 (2019).","journal-title":"Sci. Transl. Med."},{"key":"641_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40478-020-0880-6","volume":"8","author":"O Al-Dalahmah","year":"2020","unstructured":"Al-Dalahmah, O. et al. Single-nucleus RNA-seq identifies Huntington disease astrocyte states. Acta Neuropathol. Commun. 8, 19 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"641_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","volume":"23","author":"N Habib","year":"2020","unstructured":"Habib, N. et al. Disease-associated astrocytes in Alzheimer\u2019s disease and aging. Nat. Neurosci. 23, 701\u2013706 (2020).","journal-title":"Nat. Neurosci."},{"key":"641_CR19","doi-asserted-by":"publisher","first-page":"25800","DOI":"10.1073\/pnas.2008762117","volume":"117","author":"S-F Lau","year":"2020","unstructured":"Lau, S.-F., Cao, H., Fu, A. K. Y. & Ip, N. Y. Single-nucleus transcriptome analysis reveals dysregulation of angiogenic endothelial cells and neuroprotective glia in Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 117, 25800\u201325809 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"641_CR20","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41593-020-00764-7","volume":"24","author":"K Leng","year":"2021","unstructured":"Leng, K. et al. Molecular characterization of selectively vulnerable neurons in Alzheimer\u2019s disease. Nat. Neurosci. 24, 276\u2013287 (2021).","journal-title":"Nat. Neurosci."},{"key":"641_CR21","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1523\/JNEUROSCI.3693-15.2016","volume":"36","author":"R Jiang","year":"2016","unstructured":"Jiang, R., Diaz-Castro, B., Looger, L. L. & Khakh, B. S. Dysfunctional calcium and glutamate signaling in striatal astrocytes from Huntington\u2019s disease model mice. J. Neurosci. 36, 3453\u20133470 (2016).","journal-title":"J. Neurosci."},{"key":"641_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71329-8","volume":"10","author":"TM Sonninen","year":"2020","unstructured":"Sonninen, T. M. et al. Metabolic alterations in Parkinson\u2019s disease astrocytes. Sci. Rep. 10, 14474 (2020).","journal-title":"Sci. Rep."},{"key":"641_CR23","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1523\/JNEUROSCI.5308-07.2008","volume":"28","author":"P Cassina","year":"2008","unstructured":"Cassina, P. et al. Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants. J. Neurosci. 28, 4115\u20134122 (2008).","journal-title":"J. Neurosci."},{"key":"641_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.5483\/BMBRep.2017.50.5.038","volume":"50","author":"JR Bae","year":"2017","unstructured":"Bae, J. R. & Kim, S. H. Synapses in neurodegenerative diseases. BMB Rep. 50, 237\u2013246 (2017).","journal-title":"BMB Rep."},{"key":"641_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","volume":"24","author":"C Escartin","year":"2021","unstructured":"Escartin, C. et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat. Neurosci. 24, 312\u2013325 (2021).","journal-title":"Nat. Neurosci."},{"key":"641_CR26","doi-asserted-by":"publisher","first-page":"109048","DOI":"10.1016\/j.celrep.2021.109048","volume":"35","author":"MR Williamson","year":"2021","unstructured":"Williamson, M. R., Fuertes, C. J. A., Dunn, A. K., Drew, M. R. & Jones, T. A. Reactive astrocytes facilitate vascular repair and remodeling after stroke. Cell Rep. 35, 109048 (2021).","journal-title":"Cell Rep."},{"key":"641_CR27","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/glia.22723","volume":"62","author":"Z Liu","year":"2014","unstructured":"Liu, Z. et al. Beneficial effects of gfap\/vimentin reactive astrocytes for axonal remodeling and motor behavioral recovery in mice after stroke. Glia 62, 2022\u20132033 (2014).","journal-title":"Glia"},{"key":"641_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1096\/fj.12-208660","volume":"27","author":"AW Kraft","year":"2013","unstructured":"Kraft, A. W. et al. Attenuating astrocyte activation accelerates plaque pathogenesis in APP\/PS1 mice. FASEB J. 27, 187\u2013198 (2013).","journal-title":"FASEB J."},{"key":"641_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487 (2017).","journal-title":"Nature"},{"key":"641_CR30","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","volume":"32","author":"JL Zamanian","year":"2012","unstructured":"Zamanian, J. L. et al. Genomic analysis of reactive astrogliosis. J. Neurosci. 32, 6391\u20136410 (2012).","journal-title":"J. Neurosci."},{"key":"641_CR31","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.neuron.2020.03.025","volume":"106","author":"AYS Huang","year":"2020","unstructured":"Huang, A. Y. S. et al. Region-specific transcriptional control of astrocyte function oversees local circuit activities. Neuron 106, 992\u20131008.e1009 (2020).","journal-title":"Neuron"},{"key":"641_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1126\/science.1222381","volume":"337","author":"H-h Tsai","year":"2012","unstructured":"Tsai, H.-h et al. Regional astrocyte allocation regulates CNS synaptogenesis and repair. Science 337, 358\u2013362 (2012).","journal-title":"Science"},{"key":"641_CR33","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.euroneuro.2013.03.007","volume":"25","author":"TA Bayer","year":"2015","unstructured":"Bayer, T. A. Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders? Eur. Neuropsychopharmacol. 25, 713\u2013724 (2015).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"641_CR34","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1073\/pnas.1300398110","volume":"110","author":"A Serio","year":"2013","unstructured":"Serio, A. et al. Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc. Natl Acad. Sci. USA 110, 4697\u20134702 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"641_CR35","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0006-8993(88)90410-6","volume":"463","author":"TG Beach","year":"1988","unstructured":"Beach, T. G. & McGeer, E. G. Lamina-specific arrangement of astrocytic gliosis and senile plaques in Alzheimer\u2019s disease visual cortex. Brain Res. 463, 357\u2013361 (1988).","journal-title":"Brain Res."},{"key":"641_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13024-017-0194-8","volume":"12","author":"A Bosson","year":"2017","unstructured":"Bosson, A. et al. TRPA1 channels promote astrocytic Ca2+ hyperactivity and synaptic dysfunction mediated by oligomeric forms of amyloid- \u03b2 peptide. Mol. Neurodegener. 12, 53 (2017).","journal-title":"Mol. Neurodegener."},{"key":"641_CR37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fnagi.2018.00114","volume":"10","author":"BG Perez-Nievas","year":"2018","unstructured":"Perez-Nievas, B. G. & Serrano-Pozo, A. Deciphering the astrocyte reaction in Alzheimer\u2019s disease. Front. Aging Neurosci. 10, 114 (2018).","journal-title":"Front. Aging Neurosci."},{"key":"641_CR38","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff, J. J. et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci. Transl. Med. 4, 147ra111 (2012).","journal-title":"Sci. Transl. Med."},{"key":"641_CR39","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nrn1252","volume":"4","author":"M Amiry-Moghaddam","year":"2003","unstructured":"Amiry-Moghaddam, M. & Ottersen, O. P. The molecular basis of water transport in the brain. Nat. Rev. Neurosci. 4, 991\u20131001 (2003).","journal-title":"Nat. Rev. Neurosci."},{"key":"641_CR40","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1523\/JNEUROSCI.1865-20.2020","volume":"41","author":"NS Caron","year":"2021","unstructured":"Caron, N. S. et al. Mutant huntingtin is cleared from the brain via active mechanisms in Huntington disease. J. Neurosci. 41, 780\u2013796 (2021).","journal-title":"J. Neurosci."},{"key":"641_CR41","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nn.3691","volume":"17","author":"X Tong","year":"2014","unstructured":"Tong, X. et al. Astrocyte Kir4. 1 ion channel deficits contribute to neuronal dysfunction in Huntington\u2019s disease model mice. Nat. Neurosci. 17, 694\u2013703 (2014).","journal-title":"Nat. Neurosci."},{"key":"641_CR42","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1097\/NEN.0b013e3182632566","volume":"71","author":"A Hoshi","year":"2012","unstructured":"Hoshi, A. et al. Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease. J. Neuropathol. Exp. Neurol. 71, 750\u2013759 (2012).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"641_CR43","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13024-015-0056-1","volume":"10","author":"Z Xu","year":"2015","unstructured":"Xu, Z. et al. Deletion of aquaporin-4 in APP\/PS1 mice exacerbates brain A\u03b2 accumulation and memory deficits. Mol. Neurodegener. 10, 58 (2015).","journal-title":"Mol. Neurodegener."},{"key":"641_CR44","doi-asserted-by":"publisher","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano, J. M. et al. Human apoE isoforms differentially regulate brain amyloid- b peptide clearance. Sci. Transl. Med. 3, 89ra57 (2011).","journal-title":"Sci. Transl. Med."},{"key":"641_CR45","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1007\/s12035-021-02327-8","volume":"58","author":"L Streubel-Gallasch","year":"2021","unstructured":"Streubel-Gallasch, L. et al. Parkinson\u2019s disease\u2013associated LRRK2 interferes with astrocyte-mediated alpha-synuclein clearance. Mol. Neurobiol. 58, 3119\u20133140 (2021).","journal-title":"Mol. Neurobiol."},{"key":"641_CR46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1152\/physrev.00042.2016","volume":"98","author":"A Verkhratsky","year":"2018","unstructured":"Verkhratsky, A. & Nedergaard, M. Physiology of astroglia. Physiological Rev. 98, 239\u2013389 (2018).","journal-title":"Physiological Rev."},{"key":"641_CR47","doi-asserted-by":"publisher","first-page":"eaai8185","DOI":"10.1126\/science.aai8185","volume":"356","author":"E Bindocci","year":"2017","unstructured":"Bindocci, E. et al. Three-dimensional Ca2+ imaging advances understanding of astrocyte biology. Science 356, eaai8185 (2017).","journal-title":"Science"},{"key":"641_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.brainresrev.2010.02.003","volume":"63","author":"A Reichenbach","year":"2010","unstructured":"Reichenbach, A., Derouiche, A. & Kirchhoff, F. Morphology and dynamics of perisynaptic glia. Brain Res. Rev. 63, 11\u201325 (2010).","journal-title":"Brain Res. Rev."},{"key":"641_CR49","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1523\/JNEUROSCI.2689-13.2014","volume":"34","author":"H Kawamata","year":"2014","unstructured":"Kawamata, H. et al. Abnormal intracellular calcium signaling and SNARE- dependent exocytosis contributes to SOD1G93A astrocyte- mediated toxicity in amyotrophic lateral sclerosis. J. Neurosci. 34, 2331\u20132348 (2014).","journal-title":"J. Neurosci."},{"key":"641_CR50","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/hmg\/ddr513","volume":"21","author":"F Martorana","year":"2012","unstructured":"Martorana, F., Brambilla, L., Valori, C. F. & Bergamaschi, C. The BH4 domain of Bcl-X L rescues astrocyte degeneration in amyotrophic lateral sclerosis by modulating intracellular calcium signals. Hum. Mol. Genet. 21, 826\u2013840 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"641_CR51","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/glia.22777","volume":"63","author":"A Bosson","year":"2015","unstructured":"Bosson, A., Boisseau, S., Buisson, A., Savasta, M. & Albrieux, M. Disruption of dopaminergic transmission remodels tripartite synapse morphology and astrocytic calcium activity within substantia nigra pars reticulata. Glia 63, 673\u2013683 (2015).","journal-title":"Glia"},{"key":"641_CR52","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/brain\/awab281","volume":"145","author":"A Paumier","year":"2021","unstructured":"Paumier, A. et al. Astrocyte\u2013neuron interplay is critical for Alzheimer\u2019s disease pathogenesis and is rescued by TRPA1 channel blockade. Brain 145, 388\u2013405 (2021).","journal-title":"Brain"},{"key":"641_CR53","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.cell.2011.07.022","volume":"146","author":"A Panatier","year":"2011","unstructured":"Panatier, A. et al. Astrocytes are endogenous regulators of basal transmission at central synapses. Cell 146, 785\u2013798 (2011).","journal-title":"Cell"},{"key":"641_CR54","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1084\/jem.20171487","volume":"215","author":"N Reichenbach","year":"2018","unstructured":"Reichenbach, N. et al. P2Y1 receptor blockade normalizes network dysfunction and cognition in an Alzheimer\u2019s disease model. J. Exp. Med. 215, 1649\u20131663 (2018).","journal-title":"J. Exp. Med."},{"key":"641_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","volume":"65","author":"NC Danbolt","year":"2001","unstructured":"Danbolt, N. C. Glutamate uptake. Prog. Neurobiol. 65, 1\u2013105 (2001).","journal-title":"Prog. Neurobiol."},{"key":"641_CR56","doi-asserted-by":"publisher","first-page":"107559","DOI":"10.1016\/j.neuropharm.2019.03.002","volume":"161","author":"E Pajarillo","year":"2019","unstructured":"Pajarillo, E., Rizor, A., Lee, J., Aschner, M. & Lee, E. The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: potential targets for neurotherapeutics. Neuropharmacology 161, 107559 (2019).","journal-title":"Neuropharmacology"},{"key":"641_CR57","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00401-022-02437-0","volume":"144","author":"L Iovino","year":"2022","unstructured":"Iovino, L. et al. Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson\u2019s disease. Acta Neuropathol. 144, 81\u2013106 (2022).","journal-title":"Acta Neuropathol."},{"key":"641_CR58","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1021\/acschemneuro.9b00609","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Generation of a novel mouse model of Parkinson\u2019s disease via targeted knockdown of glutamate transporter GLT-1 in the substantia nigra. ACS Chem. Neurosci. 11, 406\u2013417 (2020).","journal-title":"ACS Chem. Neurosci."},{"key":"641_CR59","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3233\/JPD-212640","volume":"12","author":"C Ren","year":"2022","unstructured":"Ren, C. et al. Induction of Parkinsonian-like changes via targeted downregulation of astrocytic glutamate transporter GLT-1 in the striatum. J. Parkinsons Dis. 12, 295\u2013314 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"641_CR60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00005072-197101000-00008","volume":"30","author":"JW Olney","year":"1971","unstructured":"Olney, J. W. Glutamate-induced neuronal necrosis in the infant mouse hypothalamus. J. Neuropathol. Exp. Neurol. 30, 75\u201390 (1971).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"641_CR61","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/187152710791292576","volume":"9","author":"E Bogaert","year":"2010","unstructured":"Bogaert, E., d\u2019Ydewalle, C. & Van Den Bosch, L. Amyotrophic lateral sclerosis and excitotoxicity: from pathological mechanism to therapeutic target. CNS Neurol. Disord. Drug. Targets 9, 297\u2013304 (2010).","journal-title":"CNS Neurol. Disord. Drug. Targets"},{"key":"641_CR62","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.neuint.2004.03.007","volume":"45","author":"MR Hynd","year":"2004","unstructured":"Hynd, M. R., Scott, H. L. & Dodd, P. R. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer\u2019s disease. Neurochem. Int. 45, 583\u2013595 (2004).","journal-title":"Neurochem. Int."},{"key":"641_CR63","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jphs.2020.07.011","volume":"144","author":"L Iovino","year":"2020","unstructured":"Iovino, L., Tremblay, M. E. & Civiero, L. Glutamate-induced excitotoxicity in Parkinson\u2019s disease: the role of glial cells. J. Pharmacol. Sci. 144, 151\u2013164 (2020).","journal-title":"J. Pharmacol. Sci."},{"key":"641_CR64","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.drudis.2014.02.006","volume":"19","author":"MD Sepers","year":"2014","unstructured":"Sepers, M. D. & Raymond, L. A. Mechanisms of synaptic dysfunction and excitotoxicity in Huntington\u2019s disease. Drug. Discov. Today 19, 990\u2013996 (2014).","journal-title":"Drug. Discov. Today"},{"key":"641_CR65","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fncel.2015.00318","volume":"9","author":"CA Saura","year":"2015","unstructured":"Saura, C. A., Parra-Damas, A. & Enriquez-Barreto, L. Gene expression parallels synaptic excitability and plasticity changes in Alzheimer\u2019s disease. Front. Cell. Neurosci. 9, 318 (2015).","journal-title":"Front. Cell. Neurosci."},{"key":"641_CR66","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry, R. D. et al. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572\u2013580 (1991).","journal-title":"Ann. Neurol."},{"key":"641_CR67","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3233\/JAD-170045","volume":"57","author":"G Esquerda-Canals","year":"2017","unstructured":"Esquerda-Canals, G., Montoliu-Gaya, L., G\u00fcell-Bosch, J. & Villegas, S. Mouse models of Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 57, 1171\u20131183 (2017).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"641_CR68","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fncel.2019.00063","volume":"13","author":"CM Henstridge","year":"2019","unstructured":"Henstridge, C. M., Tzioras, M. & Paolicelli, R. C. Glial contribution to excitatory and inhibitory synapse loss in neurodegeneration. Front. Cell. Neurosci. 13, 63 (2019).","journal-title":"Front. Cell. Neurosci."},{"key":"641_CR69","doi-asserted-by":"publisher","first-page":"E2518","DOI":"10.1073\/pnas.1306832110","volume":"110","author":"M Talantova","year":"2013","unstructured":"Talantova, M. et al. A\u03b2 induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. Proc. Natl Acad. Sci. USA 110, E2518\u2013E2527 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"641_CR70","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1523\/JNEUROSCI.1871-20.2020","volume":"41","author":"D Trudler","year":"2021","unstructured":"Trudler, D. et al. \u03b1-Synuclein oligomers induce glutamate release from astrocytes and excessive extrasynaptic NMDAR activity in neurons, thus contributing to synapse loss. J. Neurosci. 41, 2264\u20132273 (2021).","journal-title":"J. Neurosci."},{"key":"641_CR71","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrn2911","volume":"11","author":"GE Hardingham","year":"2010","unstructured":"Hardingham, G. E. & Bading, H. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat. Rev. Neurosci. 11, 682\u2013696 (2010).","journal-title":"Nat. Rev. Neurosci."},{"key":"641_CR72","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/glia.22548","volume":"61","author":"AN Shrivastava","year":"2013","unstructured":"Shrivastava, A. N. et al. \u03b2-Amyloid and ATP-induced diffusional trapping of astrocyte and neuronal metabotropic glutamate type-5 receptors. Glia 61, 1673\u20131686 (2013).","journal-title":"Glia"},{"key":"641_CR73","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nm.3639","volume":"20","author":"S Jo","year":"2014","unstructured":"Jo, S. et al. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer\u2019s disease. Nat. Med. 20, 886\u2013896 (2014).","journal-title":"Nat. Med."},{"key":"641_CR74","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/nn.2929","volume":"14","author":"MA Di Castro","year":"2011","unstructured":"Di Castro, M. A. et al. Local Ca2+ detection and modulation of synaptic release by astrocytes. Nat. Neurosci. 14, 1276\u20131284 (2011).","journal-title":"Nat. Neurosci."},{"key":"641_CR75","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ceca.2006.06.004","volume":"41","author":"A Minelli","year":"2007","unstructured":"Minelli, A. et al. Cellular and subcellular localization of Na+\u2013Ca2+ exchanger protein isoforms, NCX1, NCX2, and NCX3 in cerebral cortex and hippocampus of adult rat. Cell Calcium 41, 221\u2013234 (2007).","journal-title":"Cell Calcium"},{"key":"641_CR76","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/glia.20455","volume":"55","author":"YV Kucheryavykh","year":"2007","unstructured":"Kucheryavykh, Y. V. et al. Downregulation of Kir4. 1 inward rectifying potassium channel subunits by RNAi impairs potassium transfer and glutamate uptake by cultured cortical astrocytes. Glia 55, 274\u2013281 (2007).","journal-title":"Glia"},{"key":"641_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0227-9","volume":"9","author":"S Anzilotti","year":"2018","unstructured":"Anzilotti, S. et al. Preconditioning, induced by sub-toxic dose of the neurotoxin L-BMAA, delays ALS progression in mice and prevents Na+\/Ca2+ exchanger 3 downregulation. Cell Death Dis. 9, 206 (2018).","journal-title":"Cell Death Dis."},{"key":"641_CR78","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.1523\/JNEUROSCI.6429-11.2012","volume":"32","author":"A Pannaccione","year":"2012","unstructured":"Pannaccione, A. et al. A new concept: A\u03b21\u201342 generates a hyperfunctional proteolytic NCX3 fragment that delays caspase-12 activation and neuronal death. J. Neurosci. 32, 10609\u201310617 (2012).","journal-title":"J. Neurosci."},{"key":"641_CR79","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.neuron.2018.03.010","volume":"98","author":"KW Kelley","year":"2018","unstructured":"Kelley, K. W. et al. Kir4.1-dependent astrocyte-fast motor neuron interactions are required for peak strength. Neuron 98, 306\u2013319.e307 (2018).","journal-title":"Neuron"},{"key":"641_CR80","doi-asserted-by":"publisher","first-page":"7653","DOI":"10.1002\/jcp.29682","volume":"235","author":"BL Tang","year":"2020","unstructured":"Tang, B. L. Glucose, glycolysis, and neurodegenerative diseases. J. Cell Physiol. 235, 7653\u20137662 (2020).","journal-title":"J. Cell Physiol."},{"key":"641_CR81","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","volume":"14","author":"M B\u00e9langer","year":"2011","unstructured":"B\u00e9langer, M., Allaman, I. & Magistretti, P. J. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 14, 724\u2013738 (2011).","journal-title":"Cell Metab."},{"key":"641_CR82","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.cell.2011.02.018","volume":"144","author":"A Suzuki","year":"2011","unstructured":"Suzuki, A. et al. Astrocyte-neuron lactate transport is required for long-term memory formation. Cell 144, 810\u2013823 (2011).","journal-title":"Cell"},{"key":"641_CR83","doi-asserted-by":"publisher","first-page":"12228","DOI":"10.1073\/pnas.1322912111","volume":"111","author":"J Yang","year":"2014","unstructured":"Yang, J. et al. Lactate promotes plasticity gene expression by potentiating NMDA signaling in neurons. Proc. Natl Acad. Sci. USA 111, 12228\u201312233 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"641_CR84","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.2174\/1381612821666150710144502","volume":"21","author":"C Finsterwald","year":"2015","unstructured":"Finsterwald, C., Magistretti, P. J. & Lengacher, S. Astrocytes: new targets for the treatment of neurodegenerative diseases. Curr. Pharm. Des. 21, 3570\u20133581 (2015).","journal-title":"Curr. Pharm. Des."},{"key":"641_CR85","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrn2059","volume":"8","author":"JA Allen","year":"2007","unstructured":"Allen, J. A., Halverson-tamboli, R. A. & Rasenick, M. M. Lipid raft microdomains and neurotransmitter signalling. Nat. Rev. Neurosci. 8, 128\u2013140 (2007).","journal-title":"Nat. Rev. Neurosci."},{"key":"641_CR86","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.plipres.2011.06.002","volume":"50","author":"FW Pfrieger","year":"2011","unstructured":"Pfrieger, F. W. & Ungerer, N. Cholesterol metabolism in neurons and astrocytes. Prog. Lipid Res. 50, 357\u2013371 (2011).","journal-title":"Prog. Lipid Res."},{"key":"641_CR87","doi-asserted-by":"publisher","first-page":"8299","DOI":"10.1073\/pnas.0500579102","volume":"102","author":"EM Reiman","year":"2005","unstructured":"Reiman, E. M. et al. Correlations between apolipoprotein E4 gene dose and brain-imaging measurements of regional hypometabolism. Proc. Natl Acad. Sci. USA 102, 8299\u20138302 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"641_CR88","doi-asserted-by":"publisher","first-page":"104742","DOI":"10.1016\/j.nbd.2020.104742","volume":"136","author":"HC Williams","year":"2020","unstructured":"Williams, H. C. et al. APOE alters glucose flux through central carbon pathways in astrocytes. Neurobiol. Dis. 136, 104742 (2020).","journal-title":"Neurobiol. Dis."},{"key":"641_CR89","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13024-020-00382-8","volume":"15","author":"R Larramona-Arcas","year":"2020","unstructured":"Larramona-Arcas, R. et al. Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice. Mol. Neurodegener. 15, 35 (2020).","journal-title":"Mol. Neurodegener."},{"key":"641_CR90","first-page":"739","volume":"42","author":"W Jeong","year":"2019","unstructured":"Jeong, W., Lee, H., Cho, S. & Seo, J. ApoE4-induced cholesterol dysregulation and its brain cell type-specific implications in the pathogenesis of Alzheimer\u2019s disease. Mol. Cell 42, 739\u2013746 (2019).","journal-title":"Mol. Cell"},{"key":"641_CR91","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/cdd.2014.162","volume":"22","author":"M Valenza","year":"2015","unstructured":"Valenza, M. et al. Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington\u2019s disease. Cell Death Differ. 22, 690\u2013702 (2015).","journal-title":"Cell Death Differ."},{"key":"641_CR92","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1093\/brain\/awab186","volume":"144","author":"G Birolini","year":"2021","unstructured":"Birolini, G. et al. SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington\u2019s disease phenotypes. Brain 144, 3175\u20133190 (2021).","journal-title":"Brain"},{"key":"641_CR93","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16175","author":"H Hartmann","year":"2021","unstructured":"Hartmann, H., Ho, W. Y., Chang, J.-C. & Ling, S.-C. Cholesterol dyshomeostasis in amyotrophic lateral sclerosis: cause, consequence, or epiphenomenon? FEBS J. https:\/\/doi.org\/10.1111\/febs.16175 (2021).","journal-title":"FEBS J."},{"key":"641_CR94","doi-asserted-by":"publisher","first-page":"554","DOI":"10.5607\/en.2019.28.5.554","volume":"28","author":"U Jin","year":"2019","unstructured":"Jin, U., Park, S. J. & Park, S. M. Cholesterol metabolism in the brain and its association with Parkinson\u2019s disease. Exp. Neurobiol. 28, 554\u2013567 (2019).","journal-title":"Exp. Neurobiol."},{"key":"641_CR95","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/83679","volume":"27","author":"M Brenner","year":"2001","unstructured":"Brenner, M. et al. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat. Genet. 27, 117\u2013120 (2001).","journal-title":"Nat. Genet."},{"key":"641_CR96","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/306234a0","volume":"306","author":"J Gusella","year":"1983","unstructured":"Gusella, J. et al. A polymorphic DNA marker genetically linked to Huntington\u2019s disease. Nature 306, 234\u2013238 (1983).","journal-title":"Nature"},{"key":"641_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079771","volume":"8","author":"PG Ridge","year":"2013","unstructured":"Ridge, P. G., Mukherjee, S., Crane, P. K. & Kauwe, J. S. K. Alzheimer\u2019s disease: analyzing the missing heritability. PLoS One 8, e79771 (2013).","journal-title":"PLoS One"},{"key":"641_CR98","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/mds.28099","volume":"35","author":"MH Fu","year":"2020","unstructured":"Fu, M. H. et al. Recessively-inherited adult-onset Alexander disease caused by a homozygous mutation in the GFAP gene. Mov. Disord. 35, 1662\u20131667 (2020).","journal-title":"Mov. Disord."},{"key":"641_CR99","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3389\/fneur.2019.01124","volume":"10","author":"A Ciammola","year":"2019","unstructured":"Ciammola, A. et al. A novel mutation of GFAP causing adult-onset Alexander disease. Front. Neurol. 10, 1124 (2019).","journal-title":"Front. Neurol."},{"key":"641_CR100","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0896-6273(95)90238-4","volume":"14","author":"H Gomi","year":"1995","unstructured":"Gomi, H. et al. Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions. Neuron 14, 29\u201341 (1995).","journal-title":"Neuron"},{"key":"641_CR101","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/NEN.0b013e3181d3cb52","volume":"69","author":"R Tian","year":"2010","unstructured":"Tian, R. et al. Alexander disease mutant glial fibrillary acidic protein compromises glutamate transport in astrocytes. J. Neuropathol. Exp. Neurol. 69, 335\u2013345 (2010).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"641_CR102","doi-asserted-by":"publisher","first-page":"eabg4711","DOI":"10.1126\/scitranslmed.abg4711","volume":"13","author":"TL Hagemann","year":"2021","unstructured":"Hagemann, T. L. et al. Antisense therapy in a rat model of Alexander disease reverses GFAP pathology, white matter deficits, and motor impairment. Sci. Transl. Med. 13, eabg4711 (2021).","journal-title":"Sci. Transl. Med."},{"key":"641_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3917","volume":"4","author":"AI Acu\u00f1a","year":"2013","unstructured":"Acu\u00f1a, A. I. et al. A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington\u2019s disease in mice. Nat. Commun. 4, 2917 (2013).","journal-title":"Nat. Commun."},{"key":"641_CR104","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.cels.2018.05.010","volume":"7","author":"I Al-Ramahi","year":"2018","unstructured":"Al-Ramahi, I. et al. High-throughput functional analysis distinguishes pathogenic, nonpathogenic, and compensatory transcriptional changes in neurodegeneration. Cell Syst. 7, 28\u201340.e24 (2018).","journal-title":"Cell Syst."},{"key":"641_CR105","doi-asserted-by":"publisher","first-page":"16889","DOI":"10.1073\/pnas.1420103111","volume":"111","author":"J Ochaba","year":"2014","unstructured":"Ochaba, J. et al. Potential function for the Huntingtin protein as a scaffold for selective autophagy. Proc. Natl Acad. Sci. USA 111, 16889\u201316894 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"641_CR106","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.celrep.2017.12.013","volume":"22","author":"A Virlogeux","year":"2018","unstructured":"Virlogeux, A. et al. Reconstituting corticostriatal network on-a-chip reveals the contribution of the presynaptic compartment to Huntington\u2019s disease. Cell Rep. 22, 110\u2013122 (2018).","journal-title":"Cell Rep."},{"key":"641_CR107","first-page":"395","volume":"26","author":"T Maiuri","year":"2017","unstructured":"Maiuri, T. et al. Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex. Hum. Mol. Genet. 26, 395\u2013406 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"641_CR108","doi-asserted-by":"publisher","first-page":"22480","DOI":"10.1073\/pnas.0911503106","volume":"106","author":"J Bradford","year":"2009","unstructured":"Bradford, J. et al. Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc. Natl Acad. Sci. USA 106, 22480\u201322485 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"641_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11758","volume":"7","author":"A Benraiss","year":"2016","unstructured":"Benraiss, A. et al. Human glia can both induce and rescue aspects of disease phenotype in Huntington disease. Nat. Commun. 7, 11758 (2016).","journal-title":"Nat. Commun."},{"key":"641_CR110","first-page":"487","volume":"28","author":"TE Wood","year":"2019","unstructured":"Wood, T. E. et al. Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington\u2019s disease mouse model. Hum. Mol. Genet. 28, 487\u2013500 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"641_CR111","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/glia.22475","volume":"61","author":"I Choi","year":"2013","unstructured":"Choi, I. et al. PINK1 deficiency attenuates astrocyte proliferation through mitochondrial dysfunction, reduced AKT and increased p38 MAPK activation, and downregulation of EGFR. Glia 61, 800\u2013812 (2013).","journal-title":"Glia"},{"key":"641_CR112","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.73062","volume":"10","author":"A de Rus Jacquet","year":"2021","unstructured":"de Rus Jacquet, A. et al. The LRRK2 G2019S mutation alters astrocyte-to-neuron communication via extracellular vesicles and induces neuron atrophy in a human iPSC-derived model of Parkinson\u2019s disease. eLife 10, e73062 (2021).","journal-title":"eLife"},{"key":"641_CR113","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nn1876","volume":"10","author":"M Nagai","year":"2007","unstructured":"Nagai, M. et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 10, 615\u2013622 (2007).","journal-title":"Nat. Neurosci."},{"key":"641_CR114","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/s41593-021-00923-4","volume":"24","author":"K Szeb\u00e9nyi","year":"2021","unstructured":"Szeb\u00e9nyi, K. et al. Human ALS\/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology. Nat. Neurosci. 24, 1542\u20131554 (2021).","journal-title":"Nat. Neurosci."},{"key":"641_CR115","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/glia.23761","volume":"68","author":"C Zhao","year":"2019","unstructured":"Zhao, C. et al. Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology. Glia 68, 1046\u20131064 (2019).","journal-title":"Glia"},{"key":"641_CR116","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ebiom.2019.11.026","volume":"50","author":"A Birger","year":"2019","unstructured":"Birger, A. et al. Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine 50, 274\u2013289 (2019).","journal-title":"EBioMedicine"},{"key":"641_CR117","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/glia.23298","volume":"66","author":"A Kia","year":"2016","unstructured":"Kia, A., McAvoy, K., Krishnamurthy, K., Trotti, D. & Pasinelli, P. Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha. Glia 66, 1016\u20131033 (2016).","journal-title":"Glia"},{"key":"641_CR118","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.neuron.2022.02.010","volume":"110","author":"C Arredondo","year":"2022","unstructured":"Arredondo, C. et al. Excessive release of inorganic polyphosphate by ALS\/FTD astrocytes causes non-cell-autonomous toxicity to motoneurons. Neuron 110, 1656\u20131670.e1612 (2022).","journal-title":"Neuron"},{"key":"641_CR119","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1038\/emboj.2012.79","volume":"31","author":"L Chavez-Guti\u00e9rrez","year":"2012","unstructured":"Chavez-Guti\u00e9rrez, L. et al. The mechanism of \u03b3-secretase dysfunction in familial Alzheimer disease. EMBO J. 31, 2261\u20132274 (2012).","journal-title":"EMBO J."},{"key":"641_CR120","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/gim.2015.117","volume":"18","author":"C Van Cauwenberghe","year":"2016","unstructured":"Van Cauwenberghe, C., Van Broeckhoven, C. & Sleegers, K. The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet. Med. 18, 421\u2013430 (2016).","journal-title":"Genet. Med."},{"key":"641_CR121","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1523\/JNEUROSCI.2735-15.2016","volume":"36","author":"MC Liao","year":"2016","unstructured":"Liao, M. C. et al. Single-cell detection of secreted A\u03b2 and sAPP\u03b1 from human IPSC-derived neurons and astrocytes. J. Neurosci. 36, 1730\u20131746 (2016).","journal-title":"J. Neurosci."},{"key":"641_CR122","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/hmg\/ddp406","volume":"18","author":"L Bertram","year":"2009","unstructured":"Bertram, L. & Tanzi, R. E. Genome-wide association studies in Alzheimer\u2019s disease. Hum. Mol. Genet. 18, 137\u2013145 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"641_CR123","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen, I. E. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat. Genet. 51, 404\u2013413 (2019).","journal-title":"Nat. Genet."},{"key":"641_CR124","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter, W. J. et al. Apolipoprotein E: High-avidity binding to \u03b2-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 1977\u20131981 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"641_CR125","doi-asserted-by":"publisher","first-page":"30001","DOI":"10.1074\/jbc.274.42.30001","volume":"274","author":"AM Fagan","year":"1999","unstructured":"Fagan, A. M. et al. Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-\/-), and human apoE transgenic mice. J. Biol. Chem. 274, 30001\u201330007 (1999).","journal-title":"J. Biol. Chem."},{"key":"641_CR126","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","volume":"63","author":"J Kim","year":"2009","unstructured":"Kim, J., Basak, J. M. & Holtzman, D. M. The role of apolipoprotein E in Alzheimer\u2019s disease. Neuron 63, 287\u2013303 (2009).","journal-title":"Neuron"},{"key":"641_CR127","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi, Y. et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549, 523\u2013527 (2017).","journal-title":"Nature"},{"key":"641_CR128","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.62199","volume":"9","author":"M Shinohara","year":"2020","unstructured":"Shinohara, M. et al. Apoe2 is associated with longevity independent of Alzheimer\u2019s disease. eLife 9, e62199 (2020).","journal-title":"eLife"},{"key":"641_CR129","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"YT Lin","year":"2018","unstructured":"Lin, Y. T. et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron 98, 1141\u20131154.e1147 (2018).","journal-title":"Neuron"},{"key":"641_CR130","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.cell.2022.05.017","volume":"185","author":"J Tcw","year":"2022","unstructured":"Tcw, J. et al. Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. Cell 185, 2213\u20132233.e2225 (2022).","journal-title":"Cell"},{"key":"641_CR131","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1093\/hmg\/ddx155","volume":"26","author":"J Zhao","year":"2017","unstructured":"Zhao, J. et al. APOE \u03f54\/\u03f54 diminishes neurotrophic function of human iPSC-derived astrocytes. Hum. Mol. Genet. 26, 2690\u20132700 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"641_CR132","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neurobiolaging.2017.03.002","volume":"54","author":"JY Zheng","year":"2017","unstructured":"Zheng, J. Y. et al. Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer\u2019s disease (APP\/PS1) mice by inhibiting TGF-\u03b2\/Smad2\/STAT3 signaling. Neurobiol. Aging 54, 112\u2013132 (2017).","journal-title":"Neurobiol. Aging"},{"key":"641_CR133","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13024-020-00387-3","volume":"15","author":"M Taga","year":"2020","unstructured":"Taga, M. et al. BIN1 protein isoforms are differentially expressed in astrocytes, neurons, and microglia: neuronal and astrocyte BIN1 are implicated in tau pathology. Mol. Neurodegener. 15, 44 (2020).","journal-title":"Mol. Neurodegener."},{"key":"641_CR134","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-021-00426-7","volume":"16","author":"F Chen","year":"2021","unstructured":"Chen, F. et al. Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer\u2019s disease neuropathology. Mol. Neurodegener. 16, 5 (2021).","journal-title":"Mol. Neurodegener."},{"key":"641_CR135","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/00005072-199906000-00011","volume":"58","author":"O Bugiani","year":"1991","unstructured":"Bugiani, O. et al. Frontotemporal dementia and corticobasal degeneration in a family with P301S mutation in tau. J. Neuropathol. Exp. Neurol. 58, 667\u2013677 (1991).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"641_CR136","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"M Hutton","year":"1998","unstructured":"Hutton, M. et al. Association of missense and 5\u2019-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702\u2013705 (1998).","journal-title":"Nature"},{"key":"641_CR137","doi-asserted-by":"publisher","first-page":"34873","DOI":"10.1074\/jbc.M405131200","volume":"279","author":"ADC Alonso","year":"2004","unstructured":"Alonso, A. D. C., Mederlyova, A., Novak, M., Grundke-Iqbal, I. & Iqbal, K. Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. J. Biol. Chem. 279, 34873\u201334881 (2004).","journal-title":"J. Biol. Chem."},{"key":"641_CR138","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40478-017-0478-9","volume":"5","author":"M Sidoryk-Wegrzynowicz","year":"2017","unstructured":"Sidoryk-Wegrzynowicz, M. et al. Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions. Acta Neuropathol. Commun. 5, 89 (2017).","journal-title":"Acta Neuropathol. Commun."},{"key":"641_CR139","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20322-w","volume":"12","author":"P Wang","year":"2021","unstructured":"Wang, P. & Ye, Y. Filamentous recombinant human Tau activates primary astrocytes via an integrin receptor complex. Nat. Commun. 12, 95 (2021).","journal-title":"Nat. Commun."},{"key":"641_CR140","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3389\/fnins.2019.00442","volume":"13","author":"JR Perea","year":"2019","unstructured":"Perea, J. R. et al. Extracellular monomeric tau is internalized by astrocytes. Front. Neurosci. 13, 442 (2019).","journal-title":"Front. Neurosci."},{"key":"641_CR141","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fnagi.2020.00096","volume":"12","author":"GG Kovacs","year":"2020","unstructured":"Kovacs, G. G. Astroglia and tau: new perspectives. Front. Aging Neurosci. 12, 96 (2020).","journal-title":"Front. Aging Neurosci."},{"key":"641_CR142","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.neuron.2018.10.031","volume":"100","author":"A Litvinchuk","year":"2018","unstructured":"Litvinchuk, A. et al. Complement C3aR inactivation attenuates tau pathology and reverses an immune network deregulated in tauopathy models and Alzheimer\u2019s disease. Neuron 100, 1337\u20131353.e1335 (2018).","journal-title":"Neuron"},{"key":"641_CR143","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.neurobiolaging.2012.11.024","volume":"34","author":"NC Berchtold","year":"2013","unstructured":"Berchtold, N. C. et al. Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer\u2019s disease. Neurobiol. Aging 34, 1653\u20131661 (2013).","journal-title":"Neurobiol. Aging"},{"key":"641_CR144","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.neuron.2019.12.015","volume":"105","author":"B Bai","year":"2020","unstructured":"Bai, B. et al. Deep multilayer brain proteomics identifies molecular networks in Alzheimer\u2019s disease progression. Neuron 105, 975\u2013991.e977 (2020).","journal-title":"Neuron"},{"key":"641_CR145","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41593-021-00999-y","volume":"25","author":"ECB Johnson","year":"2022","unstructured":"Johnson, E. C. B. et al. Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat. Neurosci. 25, 213\u2013225 (2022).","journal-title":"Nat. Neurosci."},{"key":"641_CR146","doi-asserted-by":"publisher","first-page":"105655","DOI":"10.1016\/j.nbd.2022.105655","volume":"166","author":"E Galea","year":"2022","unstructured":"Galea, E. et al. Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer\u2019s disease. Neurobiol. Dis. 166, 105655 (2022).","journal-title":"Neurobiol. Dis."},{"key":"641_CR147","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.neuron.2022.03.008","volume":"110","author":"JS Sadick","year":"2022","unstructured":"Sadick, J. S. et al. Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer\u2019s disease. Neuron 110, 1788\u20131805.e1710 (2022).","journal-title":"Neuron"},{"key":"641_CR148","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","volume":"131","author":"B Stevens","year":"2007","unstructured":"Stevens, B. et al. The classical complement cascade mediates CNS synapse elimination. Cell 131, 1164\u20131178 (2007).","journal-title":"Cell"},{"key":"641_CR149","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys, H. et al. Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature 570, 332\u2013337 (2019).","journal-title":"Nature"},{"key":"641_CR150","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/s41593-019-0539-4","volume":"22","author":"A Grubman","year":"2019","unstructured":"Grubman, A. et al. A single-cell atlas of entorhinal cortex from individuals with Alzheimer\u2019s disease reveals cell-type-specific gene expression regulation. Nat. Neurosci. 22, 2087\u20132097 (2019).","journal-title":"Nat. Neurosci."},{"key":"641_CR151","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1016\/j.neurobiolaging.2014.06.004","volume":"35","author":"M Orre","year":"2014","unstructured":"Orre, M. et al. Isolation of glia from Alzheimer\u2019s mice reveals inflammation and dysfunction. Neurobiol. Aging 35, 2746\u20132760 (2014).","journal-title":"Neurobiol. Aging"},{"key":"641_CR152","doi-asserted-by":"publisher","first-page":"E6993","DOI":"10.1073\/pnas.1520639112","volume":"112","author":"S Sun","year":"2015","unstructured":"Sun, S. et al. Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant sod1-mediated ALS. Proc. Natl Acad. Sci. USA 112, E6993\u2013E7002 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"641_CR153","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0197-4580(03)00117-9","volume":"25","author":"KS SantaCruz","year":"2004","unstructured":"SantaCruz, K. S., Yazlovitskaya, E., Collins, J., Johnson, J. & DeCarli, C. Regional NAD(P)H:quinone oxidoreductase activity in Alzheimer\u2019s disease. Neurobiol. Aging 25, 63\u201369 (2004).","journal-title":"Neurobiol. Aging"},{"key":"641_CR154","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27702-w","volume":"13","author":"Z Jiwaji","year":"2022","unstructured":"Jiwaji, Z. et al. Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and A\u00df pathology. Nat. Commun. 13, 135 (2022).","journal-title":"Nat. Commun."},{"key":"641_CR155","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s40478-018-0606-1","volume":"6","author":"K Ceyz\u00e9riat","year":"2018","unstructured":"Ceyz\u00e9riat, K. et al. Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer\u2019s disease. Acta Neuropathol. Commun. 6, 104 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"641_CR156","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809665","volume":"11","author":"N Reichenbach","year":"2019","unstructured":"Reichenbach, N. et al. Inhibition of Stat3\u2010mediated astrogliosis ameliorates pathology in an Alzheimer\u2019s disease model. EMBO Mol. Med. 11, e9665 (2019).","journal-title":"EMBO Mol. Med."},{"key":"641_CR157","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neurobiolaging.2020.02.010","volume":"90","author":"O Guillemaud","year":"2020","unstructured":"Guillemaud, O. et al. Complex roles for reactive astrocytes in the triple transgenic mouse model of Alzheimer disease. Neurobiol. Aging 90, 135\u2013146 (2020).","journal-title":"Neurobiol. Aging"},{"key":"641_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17514-9","volume":"11","author":"KA Guttenplan","year":"2020","unstructured":"Guttenplan, K. A. et al. Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model. Nat. Commun. 11, 3753 (2020).","journal-title":"Nat. Commun."},{"key":"641_CR159","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41593-021-00905-6","volume":"24","author":"P Hasel","year":"2021","unstructured":"Hasel, P., Rose, I. V. L., Sadick, J. S., Kim, R. D. & Liddelow, S. A. Neuroinflammatory astrocyte subtypes in the mouse brain. Nat. Neurosci. 24, 1475\u20131487 (2021).","journal-title":"Nat. Neurosci."},{"key":"641_CR160","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41593-020-00787-0","volume":"24","author":"KR Maynard","year":"2021","unstructured":"Maynard, K. R. et al. Transcriptome-scale spatial gene expression in the human dorsolateral prefrontal cortex. Nat. Neurosci. 24, 425\u2013436 (2021).","journal-title":"Nat. Neurosci."},{"key":"641_CR161","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.aav9776","volume":"364","author":"S Maniatis","year":"2019","unstructured":"Maniatis, S. et al. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science 364, 89\u201393 (2019).","journal-title":"Science"},{"key":"641_CR162","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson, E. C. B. et al. Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat. Med. 26, 769\u2013780 (2020).","journal-title":"Nat. Med."},{"key":"641_CR163","doi-asserted-by":"publisher","first-page":"107807","DOI":"10.1016\/j.celrep.2020.107807","volume":"31","author":"V Swarup","year":"2020","unstructured":"Swarup, V. et al. Identification of conserved proteomic networks in neurodegenerative dementia. Cell Rep. 31, 107807 (2020).","journal-title":"Cell Rep."},{"key":"641_CR164","doi-asserted-by":"publisher","first-page":"107908","DOI":"10.1016\/j.celrep.2020.107908","volume":"32","author":"YW Wan","year":"2020","unstructured":"Wan, Y. W. et al. Meta-analysis of the Alzheimer\u2019s disease human brain transcriptome and functional dissection in mouse models. Cell Rep. 32, 107908 (2020).","journal-title":"Cell Rep."},{"key":"641_CR165","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jalz.2018.10.006","volume":"15","author":"F Xiong","year":"2019","unstructured":"Xiong, F., Ge, W. & Ma, C. Quantitative proteomics reveals distinct composition of amyloid plaques in Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 15, 429\u2013440 (2019).","journal-title":"Alzheimer\u2019s Dement."},{"key":"641_CR166","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.cbpa.2013.07.021","volume":"17","author":"FI Hinz","year":"2013","unstructured":"Hinz, F. I., Dieterich, D. C. & Schuman, E. M. Teaching old NCATs new tricks: using non-canonical amino acid tagging to study neuronal plasticity. Curr. Opin. Chem. Biol. 17, 738\u2013746 (2013).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"641_CR167","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41592-020-01010-5","volume":"18","author":"W Qin","year":"2021","unstructured":"Qin, W., Cho, K. F., Cavanagh, P. E. & Ting, A. Y. Deciphering molecular interactions by proximity labeling. Nat. Methods 18, 133\u2013143 (2021).","journal-title":"Nat. Methods"},{"key":"641_CR168","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41573-022-00390-x","volume":"21","author":"H-G Lee","year":"2022","unstructured":"Lee, H.-G., Wheeler, M. A. & Quintana, F. J. Function and therapeutic value of astrocytes in neurological diseases. Nat. Rev. Drug. Discov. 21, 339\u2013358 (2022).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"641_CR169","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ana.24794","volume":"80","author":"KA Vossel","year":"2016","unstructured":"Vossel, K. A. et al. Incidence and impact of subclinical epileptiform activity in Alzheimer\u2019s disease. Ann. Neurol. 80, 858\u2013870 (2016).","journal-title":"Ann. Neurol."},{"key":"641_CR170","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.clinph.2021.03.050","volume":"132","author":"AA Horvath","year":"2021","unstructured":"Horvath, A. A. et al. Subclinical epileptiform activity accelerates the progression of Alzheimer\u2019s disease: a long-term EEG study. Clin. Neurophysiol. 132, 1982\u20131989 (2021).","journal-title":"Clin. Neurophysiol."},{"key":"641_CR171","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/14728222.2020.1815191","volume":"24","author":"D Souza Monteiro de Araujo","year":"2020","unstructured":"Souza Monteiro de Araujo, D., Nassini, R., Geppetti, P. & De Logu, F. TRPA1 as a therapeutic target for nociceptive pain. Expert. Opin. Ther. Targets 24, 997\u20131008 (2020).","journal-title":"Expert. Opin. Ther. Targets"},{"key":"641_CR172","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.resp.2015.10.003","volume":"226","author":"V Rajani","year":"2016","unstructured":"Rajani, V., Zhang, Y., Revill, A. L. & Funk, G. D. The role of P2Y1 receptor signaling in central respiratory control. Respir. Physiol. Neurobiol. 226, 3\u201310 (2016).","journal-title":"Respir. Physiol. Neurobiol."},{"key":"641_CR173","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64564","volume":"10","author":"TS Onur","year":"2021","unstructured":"Onur, T. S. et al. Downregulation of glial genes involved in synaptic function mitigates Huntington\u2019s disease pathogenesis. eLife 10, e64564 (2021).","journal-title":"eLife"},{"key":"641_CR174","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0599-5","volume":"9","author":"JF Moruno-Manchon","year":"2018","unstructured":"Moruno-Manchon, J. F. et al. Sphingosine kinase 1-associated autophagy differs between neurons and astrocytes. Cell Death Dis. 9, 521 (2018).","journal-title":"Cell Death Dis."},{"key":"641_CR175","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.1172\/JCI127492","volume":"129","author":"D Laug","year":"2019","unstructured":"Laug, D. et al. Nuclear factor I-A regulates diverse reactive astrocyte responses after CNS injury. J. Clin. Invest. 129, 4408\u20134418 (2019).","journal-title":"J. Clin. Invest."},{"key":"641_CR176","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1080\/15592294.2014.1001219","volume":"10","author":"NC Chisholm","year":"2015","unstructured":"Chisholm, N. C. et al. Histone methylation patterns in astrocytes are influenced by age following ischemia. Epigenetics 10, 142\u2013152 (2015).","journal-title":"Epigenetics"},{"key":"641_CR177","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1762-8","volume":"20","author":"G Liu","year":"2019","unstructured":"Liu, G., Yin, K., Zhang, Q., Gao, C. & Qiu, J. L. Modulating chromatin accessibility by transactivation and targeting proximal dsgRNAs enhances Cas9 editing efficiency in vivo. Genome Biol. 20, 145 (2019).","journal-title":"Genome Biol."},{"key":"641_CR178","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nbt.3199","volume":"33","author":"IB Hilton","year":"2015","unstructured":"Hilton, I. B. et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat. Biotechnol. 33, 510\u2013517 (2015).","journal-title":"Nat. Biotechnol."},{"key":"641_CR179","doi-asserted-by":"publisher","DOI":"10.1038\/srep22605","volume":"6","author":"G Esposito","year":"2016","unstructured":"Esposito, G. et al. Autologous transplantation of intestine-isolated glia cells improves neuropathology and restores cognitive deficits in \u03b2 amyloid-induced neurodegeneration. Sci. Rep. 6, 22605 (2016).","journal-title":"Sci. Rep."},{"key":"641_CR180","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41586-020-2388-4","volume":"582","author":"H Qian","year":"2020","unstructured":"Qian, H. et al. Reversing a model of Parkinson\u2019s disease with in situ converted nigral neurons. Nature 582, 550\u2013556 (2020).","journal-title":"Nature"},{"key":"641_CR181","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.cell.2020.03.024","volume":"181","author":"H Zhou","year":"2020","unstructured":"Zhou, H. et al. Glia-to-neuron conversion by CRISPR-CasRx alleviates symptoms of neurological disease in mice. Cell 181, 590\u2013603.e516 (2020).","journal-title":"Cell"},{"key":"641_CR182","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1016\/j.cell.2021.09.005","volume":"184","author":"LL Wang","year":"2021","unstructured":"Wang, L. L. et al. Revisiting astrocyte to neuron conversion with lineage tracing in vivo. Cell 184, 5465\u20135481.e5416 (2021).","journal-title":"Cell"},{"key":"641_CR183","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.neuron.2021.11.023","volume":"110","author":"R Bocchi","year":"2022","unstructured":"Bocchi, R., Masserdotti, G. & G\u00f6tz, M. Direct neuronal reprogramming: fast forward from new concepts toward therapeutic approaches. Neuron 110, 366\u2013393 (2022).","journal-title":"Neuron"},{"key":"641_CR184","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.stemcr.2014.10.007","volume":"3","author":"C Heinrich","year":"2014","unstructured":"Heinrich, C. et al. Sox2-mediated conversion of NG2 glia into induced neurons in the injured adult cerebral cortex. Stem Cell Rep. 3, 1000\u20131014 (2014).","journal-title":"Stem Cell Rep."},{"key":"641_CR185","doi-asserted-by":"publisher","first-page":"10738","DOI":"10.1073\/pnas.92.23.10738","volume":"92","author":"BD Gitter","year":"1995","unstructured":"Gitter, B. D., Cox, L. M., Rydel, R. E. & May, P. C. Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells. Proc. Natl Acad. Sci. 92, 10738\u201310741 (1995).","journal-title":"Proc. Natl Acad. Sci."},{"key":"641_CR186","doi-asserted-by":"publisher","first-page":"a004457","DOI":"10.1101\/cshperspect.a004457","volume":"3","author":"DJ Selkoe","year":"2011","unstructured":"Selkoe, D. J. Alzheimer\u2019s disease. Cold Spring Harb. Perspect. Biol. 3, a004457 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"641_CR187","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1126\/science.abi6401","volume":"373","author":"DJ Selkoe","year":"2021","unstructured":"Selkoe, D. J. Treatments for Alzheimer\u2019s disease emerge. Science 373, 624\u2013626 (2021).","journal-title":"Science"},{"key":"641_CR188","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.410350507","volume":"35","author":"IA Simpson","year":"1994","unstructured":"Simpson, I. A., Chundu, K. R., Davies-Hill, T., Honer, W. G. & Davies, P. Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer\u2019s disease. Ann. Neurol. 35, 546\u2013551 (1994).","journal-title":"Ann. Neurol."},{"key":"641_CR189","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.neurobiolaging.2008.05.015","volume":"31","author":"JE Simpson","year":"2010","unstructured":"Simpson, J. E. et al. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol. Aging 31, 578\u2013590 (2010).","journal-title":"Neurobiol. Aging"},{"key":"641_CR190","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.neuroscience.2009.01.023","volume":"159","author":"DM Wilcock","year":"2009","unstructured":"Wilcock, D. M., Vitek, M. P. & Colton, C. A. Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer\u2019s disease. Neuroscience 159, 1055\u20131069 (2009).","journal-title":"Neuroscience"},{"key":"641_CR191","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/nbt.1957","volume":"29","author":"AM Haidet-Phillips","year":"2011","unstructured":"Haidet-Phillips, A. M. et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 29, 824\u2013828 (2011).","journal-title":"Nat. Biotechnol."},{"key":"641_CR192","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman, O. et al. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Prim. 3, 17071 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"641_CR193","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3389\/fnins.2020.00824","volume":"14","author":"M Izrael","year":"2020","unstructured":"Izrael, M., Slutsky, S. G. & Revel, M. Rising stars: astrocytes as a therapeutic target for ALS disease. Front. Neurosci. 14, 824 (2020).","journal-title":"Front. Neurosci."},{"key":"641_CR194","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1056\/NEJM199205283262204","volume":"326","author":"JD Rothstein","year":"1992","unstructured":"Rothstein, J. D., Martin, L. J. & Kuncl, R. W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326, 1464\u20131468 (1992).","journal-title":"N. Engl. J. Med."},{"key":"641_CR195","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0022-510X(96)00073-1","volume":"139","author":"D Schiffer","year":"1996","unstructured":"Schiffer, D., Cordera, S., Cavalla, P. & Migheli, A. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis. J. Neurological Sci. 139, 27\u201333 (1996).","journal-title":"J. Neurological Sci."},{"key":"641_CR196","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-017-0739-9","volume":"17","author":"KJ Wyant","year":"2017","unstructured":"Wyant, K. J., Ridder, A. J. & Dayalu, P. Huntington\u2019s disease \u2014 update on treatments. Curr. Neurol. Neurosci. Rep. 17, 33 (2017).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"641_CR197","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio, A. & Schwarzschild, M. A. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 15, 1257\u20131272 (2016).","journal-title":"Lancet Neurol."},{"key":"641_CR198","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.3390\/cells9122623","volume":"9","author":"I Miyazaki","year":"2020","unstructured":"Miyazaki, I. & Asanuma, M. Neuron-astrocyte interactions in Parkinson\u2019s disease. Cells 9, 2623 (2020).","journal-title":"Cells"},{"key":"641_CR199","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"O-B Tysnes","year":"2017","unstructured":"Tysnes, O.-B. & Storstein, A. Epidemiology of Parkinson\u2019s disease. J. Neural Transm. 124, 901\u2013905 (2017).","journal-title":"J. Neural Transm."},{"key":"641_CR200","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/PL00007400","volume":"99","author":"K Wakabayashi","year":"2000","unstructured":"Wakabayashi, K., Hayashi, S., Yoshimoto, M., Kudo, H. & Takahashi, H. NACP\/\u03b1-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson\u2019s disease brains. Acta Neuropathol. 99, 14\u201320 (2000).","journal-title":"Acta Neuropathol."}],"container-title":["Nature Reviews Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41583-022-00641-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41583-022-00641-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41583-022-00641-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T09:14:38Z","timestamp":1671182078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41583-022-00641-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":200,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["641"],"URL":"https:\/\/doi.org\/10.1038\/s41583-022-00641-1","relation":{},"ISSN":["1471-003X","1471-0048"],"issn-type":[{"value":"1471-003X","type":"print"},{"value":"1471-0048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"assertion":[{"value":"21 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}